Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation
Which stocks are undervalued right now? Check free
Discover now →
Primary Health Properties PLC (PHPRF) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of Primary Health Properties PLC $2.32, price $1.22, upside +90.2%, quality 30 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Fair value above price? Yes
- Good quality? No
- Add to watchlist
PH
Broad data
Sep 24, 2026
Broad data
Sep 24, 2026
Primary Health Properties PLC
PHPRF · USCheap, value-trap riskThe stock looks deeply undervalued, but low quality raises value-trap risk.
✓Fair value $2.32 · Strongly undervalued (+90.2%)
!Quality 30/100
!Mixed Growth (revenue 5y +15.0 %/yr)
✓Highly profitable · 45.8% net margin (TTM)
✓generates free cash flow
!5.8% dividend yield · Pays more than it earns
!Moderate moat 64/100
!The models disagree: range $1.40 to $4.64
Watch Primary Health Properties PLC for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.
Watch for free
Pro now: $1 first month
What runs behind every stock
26
valuation models
8 families, DCF to NCAV
37
quality factors
margins, balance sheet, cashflow, debt
6
AI factors
moat, what no ratio measures
2,000+
data points
verified, per stock, median
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range $0.9099 – $1.52 · fair‑value band $1.40 – $4.64 · the $1.22 price screens below the $2.32 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Company profile
Primary Health Properties PLC (PHP) is a UK Real Estate Investment Trust and leading investor in modern primary healthcare premises. We invest in flexible, modern properties for local primary healthcare. The overall objective of the group is to create progressive returns to shareholders through a combination of earnings growth and capital appreciation.
Show more
Primary Health Properties PLC (PHP) is a UK Real Estate Investment Trust and leading investor in modern primary healthcare premises. We invest in flexible, modern properties for local primary healthcare. The overall objective of the group is to create progressive returns to shareholders through a combination of earnings growth and capital appreciation. To achieve this, PHP invests in healthcare real estate let on long-term leases, backed by secure underlying covenants where the majority of rental income is funded directly or indirectly by a government body. Primary Health Properties Plc was incorporated in 1994 in United Kingdom.
Stock analysis
Primary Health Properties PLC (PHPRF) currently trades at $1.22, while our model-based Fair Value estimate is $2.32, implying the stock looks roughly 47.4% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $2.21 per share, and 10 of the 16 models we run sit above the $1.22 price.
Bear case: the Asset-Based group reads lowest at $0.8700, and 6 of the 16 models stay below the price. Evidence for this calculation is high.
Scenario range: $1.40 (bear) to $4.64 (bull), the price of $1.22 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 30/100 (below-average quality), in the Real Estate sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Primary Health Properties PLC reported revenue of £259M in FY2025 versus £223M in FY2021, a compound +3.8%/yr. Reported net income was £119M in FY2025, compounding −4.0%/yr from FY2021.
Key figures
Market cap $3.4B · P/E ratio 13.6 · P/S ratio 6.23 · EPS (TTM) $0.0900 · Dividend yield 5.8% · Net margin 45.9% · Return on equity 6.1% · Return on assets (EBIT) 3.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 46 out of 100 (low confidence).
What moves the price
The share trades about 14% below its 52-week high and 13% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Real Estate peers we cover trades at 6% fair-value upside, at 90%, PHPRF screens cheaper than that median.
Fair Value models
Bear $1.40
Fair Value $2.32
Bull $4.64
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then ($0.0144 per share) are deliberately not added.
Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.
Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Residual Income
$0.9900
$1.00
$1.04
74
FCF DCF
$1.44
$2.21
$4.61
71
Growth DCF
$1.35
$2.56
$4.51
70
All 16 models by family
DCF Models
FCF DCF
$1.44
$2.21
$4.61
71
5Y Revenue Exit
$0.9300
$1.53
$2.77
65
5Y EBITDA Exit
$1.39
$2.46
$4.56
67
10Y Revenue Exit
$1.07
$2.15
$2.78
62
10Y EBITDA Exit
$1.43
$3.13
$6.07
59
Dividend Discount
Gordon GGM
$0.6500
$1.29
$1.95
64
DDM Multi-Stage
$0.6500
$1.11
$1.36
65
Multiples
P/S Multiple
$0.6400
$0.8600
$1.07
58
P/B Multiple
$0.7700
$1.03
$1.29
55
EV/EBIT
$1.71
$2.28
$2.84
63
EV/EBITDA
$1.33
$1.77
$2.21
64
EV/Revenue
$0.6600
$0.9400
$1.21
51
Asset-Based
NCAV (Graham)
$0.6500
$0.8700
$1.30
51
Growth DCF
Growth DCF
$1.35
$2.56
$4.51
70
Rev-Margin DCF
$0.9900
$1.68
$3.10
65
Economic Profit
Residual Income
$0.9900
$1.00
$1.04
74
Notify me when PHPRF reaches fair value
Put PHPRF on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Quality Score breakdown
Overall quality
30/100
Of which business quality 34 · Market factors (momentum, volatility) 49
Profitability
33
Margins and returns on capital today
Quality Growth
42
Are margins and returns improving?
Cashflow
56
Earnings quality: real cash, not paper profit
Fin. Strength
47
Balance sheet, leverage, solvency risk
Investment
0
Disciplined investing over empire-building
Low Volatility
72
Calm price path (market factor)
Momentum
42
Price trend over the last 3–12 months (market factor)
52W Momentum
38
Distance to the 52-week high (market factor)
Net Issuance
0
Share count: buybacks or dilution?
Revenue & earnings trend
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.
81/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+176.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+44.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.0%
Start year 2020 (pandemic). Over 10 years: +15.3% a year
Revenue growth 30 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+30.8%
’13
’14
’15
’16
’17
’18
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
−9.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year−15.7%
Dividend (yield on the price)5.8%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−11.3% vs −4.0%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.87% → 78%
2025 sits 59% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Start year 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes less growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+9.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+3.7%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in GBP, UK: IMF forecast 2.3% a year to 2030, 3.3% from 2016 to 2025) that is about +6.9% a year for the price and +1.4% for the forecasts.
Forecast 2026 (sales)+29.0%
Forecast 2027 (sales)−2.7%
Projected 2028 (sales)−2.1%
Projected 2029 (sales)−1.5%
Projected 2030 (sales)−0.9%
Watch PHPRF, get fair value alerts →
Compare Primary Health Properties PLC with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.REIT - Healthcare Facilities · 25 stocks
Beats the industry median on 6/13 measures
A mixed picture versus its industry peers.
Valuation Multiplesvs REIT - Healthcare Facilities median · lower = cheaper
Context: sector, industry, market
- Is the Real Estate sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Undervalued stocks: Real Estate
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
None of the checked exposures detected
Similar stocks
10 more REIT - Healthcare Facilities stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Welltower Inc WELL | $230.24 | $74.85 | −67% |
| Ventas, Inc VTR | $86.59 | $34.57 | −60% |
| Omega Healthcare Investors, Inc OHI | $46.68 | $57.16 | +22% |
| Healthpeak Properties, Inc DOC | $19.44 | $16.01 | −18% |
| American Healthcare REIT, Inc AHR | $52.02 | $15.32 | −71% |
| CareTrust REIT, Inc CTRE | $37.42 | $39.79 | +6% |
| Healthcare Realty Trust Incorporated HR | $18.05 | $20.82 | +15% |
| Aedifica NV AED | €64.50 | €59.72 | −7% |
| Sabra Health Care REIT, Inc SBRA | $19.85 | $22.26 | +12% |
| National Health Investors, Inc NHI | $66.66 | $70.75 | +6% |
Explore undervalued stocks
More undervalued Real Estate stocks →
All undervalued stocks
TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
🥇 Backtested Best
🏆 Big Names
⭐ Top Rated
💎 Quality on Sale
🚀 Profitable Growth
🧊 Quality Compounders
💵 Dividend Stars
📈 Strong Momentum
📉 Fallen Angels
⚖️ Deeply Undervalued
🔍 Small-Cap Gems
🏰 Moat at a Fair Price
💼 Insider Buying
🎩 Buffett-Style Quality
📚 Peter Lynch GARP
🧮 Greenblatt Magic Formula
🛡️ Graham Defensive
Discover tools
Stock screenerFilter by region, size and sector
Compare toolTwo stocks side by side
Extrinsic Value Calculator…Calculator with industry benchmark
Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
Frequently asked questions
Is Primary Health Properties PLC (PHPRF) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $2.32 versus a price of $1.22, about +90% upside (undervalued).
What is the fair value of PHPRF?
Our model-based fair value for Primary Health Properties PLC is $2.32 (as of Sep 24, 2026), built from audited fundamentals. The current price: $1.22.
What is the quality score of PHPRF?
Primary Health Properties PLC has a Quality Score of 30/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Primary Health Properties PLC (PHPRF)?
Our model-based price target is the fair value of $2.32 (as of Sep 24, 2026) from 16 valuation models. Cautious scenario $1.40, optimistic scenario $4.64. It is a calculation from audited fundamentals, not an analyst target.
What is the Primary Health Properties PLC stock forecast for 2026?
Our models put fair value at $2.32, about +90% upside versus a price of $1.22 (undervalued). Cautious scenario $1.40, optimistic scenario $4.64. The calculation is refreshed regularly with new filings.
What is the revenue of Primary Health Properties PLC (PHPRF)?
Primary Health Properties PLC reported trailing-twelve-month revenue of about £260M (latest available figure, as of Sep 24, 2026).
Does Primary Health Properties PLC pay a dividend?
Primary Health Properties PLC currently shows a dividend yield of about 5.82% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Primary Health Properties PLC (PHPRF)?
For today's price to be fair in a discounted-cash-flow model, Primary Health Properties PLC would have to grow free cash flow by +9.3 % per year for five years (discount rate 9.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +15.0 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of PHPRF use?
Our models discount Primary Health Properties PLC at 9.2 %: a base by market capitalisation (mid), damped by beta 0.79, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Primary Health Properties PLC that is +9.3 % per year a year over ten years, using the same discount rate (9.2 %) and the same formula as our fair value.
How much growth has Primary Health Properties PLC (PHPRF) delivered so far?
Over the past 5 years revenue at Primary Health Properties PLC grew +15.0 % a year. The price currently implies +9.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Primary Health Properties PLC (PHPRF) growing?
The median revenue growth in the sector is +1.7 % a year. That is the yardstick for the growth priced into Primary Health Properties PLC (+9.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Primary Health Properties PLC (PHPRF)?
The free-cash-flow yield on the price is 4.67 %: that much free cash flow Primary Health Properties PLC produces per unit of market value. When it exceeds the discount rate of our models (9.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Primary Health Properties PLC (PHPRF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Primary Health Properties PLC it is $2.32 per share (as of Sep 24, 2026), against a price of $1.22. It is the blended result of 16 valuation models (cash flow, earnings, asset, dividend).
Is Primary Health Properties PLC stock overvalued or undervalued in 2026?
As of Sep 24, 2026, PHPRF trades below its calculated fair value: price $1.22, fair value $2.32, a gap of about +90% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of PHPRF?
No. The price is what the market pays today ($1.22); the fair value is what the company's own numbers justify ($2.32). For Primary Health Properties PLC the two are $1.10 per share apart. That gap is exactly why we show both numbers side by side.
How much is Primary Health Properties PLC worth?
The market values Primary Health Properties PLC at about $3.4B (market capitalisation, as of Sep 24, 2026). Per share that is $1.22; our models calculate a fair value of $2.32 per share.
What do the bullish and bearish scenarios say about PHPRF?
Our models span a range for Primary Health Properties PLC: cautious scenario $1.40, base $2.32, optimistic $4.64 per share (as of Sep 24, 2026, price $1.22). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of PHPRF?
Primary Health Properties PLC trades at a price-to-earnings ratio of 13.6 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $2.32 is built from several models across several years. Other multiples: P/B 1.3, P/S 13.1, EV/EBITDA 15.9.
How solid is the balance sheet of Primary Health Properties PLC (PHPRF)?
Balance-sheet figures for Primary Health Properties PLC (as of Sep 24, 2026): return on equity 6.1%. They feed the Quality Score of 30/100, which measures business quality independently of the share price.
How far is PHPRF from its 52-week high?
Primary Health Properties PLC trades at $1.22, about 14% below its 52-week high of $1.42 and 13% above the low of $1.08 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of $2.32 is for.
Which stocks are comparable to Primary Health Properties PLC?
From the same area (Real Estate) we also value Welltower Inc, Ventas, Inc, Omega Healthcare Investors, Inc, Healthpeak Properties, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Primary Health Properties PLC stock attractive at the current price?
The data as of Sep 24, 2026: price $1.22, calculated fair value $2.32 (+90%), Quality Score 30/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of PHPRF calculated?
We run Primary Health Properties PLC through 16 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $2.32, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Primary Health Properties PLC currently trades 47 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Primary Health Properties PLC (PHPRF)?
The closing price on Oct 2, 2026 was $1.22. Our model-based fair value is $2.32, about +90% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Primary Health Properties PLC right now?
The large discount to fair value meets weak quality (30/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($1.40). The market is more pessimistic than our downside scenario. The model range is unusually wide ($1.40 to $4.64). The outcome hinges heavily on assumptions, so read the point estimate with caution. As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Where does the earnings growth of Primary Health Properties PLC (PHPRF) come from?
Earnings per share at Primary Health Properties PLC grew −8.7 % a year from 2014 to 2025. Broken into its drivers: revenue per share +0.8 %, EBIT margin −3.4 %, tax rate +7.5 %, residual (interest, one-offs) −12.8 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Primary Health Properties PLC
How large is the market capitalisation of Primary Health Properties PLC (PHPRF)?
The market capitalisation of Primary Health Properties PLC is $3.4B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Primary Health Properties PLC (PHPRF)?
The price-to-sales ratio of Primary Health Properties PLC is 6.23 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Primary Health Properties PLC (PHPRF)?
Earnings per share at Primary Health Properties PLC are $0.0900 (price ÷ EPS = P/E 13.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Primary Health Properties PLC (PHPRF)?
The dividend yield of Primary Health Properties PLC is 5.8% (payout 78.9%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Primary Health Properties PLC (PHPRF)?
The net margin of Primary Health Properties PLC is 45.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Primary Health Properties PLC (PHPRF)?
The return on equity (ROE) of Primary Health Properties PLC is 6.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Primary Health Properties PLC (PHPRF)?
On an EBIT basis the return on assets of Primary Health Properties PLC is 3.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Primary Health Properties PLC (PHPRF)?
The operating margin of Primary Health Properties PLC is 81.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Primary Health Properties PLC (PHPRF)?
Revenue at Primary Health Properties PLC is growing +89.0% versus a year earlier (3y avg +44.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Primary Health Properties PLC (PHPRF)?
Earnings per share at Primary Health Properties PLC are growing −6.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Primary Health Properties PLC (PHPRF) carry?
The net debt of Primary Health Properties PLC is £3.3B (fiscal year 2025, ≈ 31.6 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Primary Health Properties PLC in the live analysis
One click puts Primary Health Properties PLC on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.